Dianthus Therapeutics | MGTA - مصاريف البيع والإدارة

سعر السهم
87.39
التغيير اليومي
-2.43 -2.71%
شهريا
9.77%
سنويا
303.28%
Q2 التوقعات
85.52




مصاريف البيع والإدارة تغيير تاريخ
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Avita Medical AUD 19.03M 1.95M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
IQVIA Holdings USD 468M 46M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 308M 40M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Organon & Co USD 399M 54M 2025-09
Ovoca Bio EUR 632K 2.33M 2025-06
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Revvity USD 251.73M 9.82M 2025-12
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 1.03B 144.1M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09